This federal contract award is for the delivery of VELCADE 3.5 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a total ceiling value of $4,341.32. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This particular delivery order has a firm fixed-price pricing type and a completion date of January 10, 2025. The contract was awarded on December 18, 2024 and does not have a set-aside designation, indicating open competition.
Generated 3/19/25, 9:52 AM